| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10220367 | European Journal of Surgical Oncology (EJSO) | 2018 | 7 Pages |
Abstract
The routine use of Bevacizumab in association with Folfox significantly reduced CALI prevalence, in turn linked to severe postoperative complications.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Catherine Hubert, Valerio Lucidi, Joseph Weerts, Alexandra Dili, Pieter Demetter, Brigitte Massart, Mina Komuta, Julie Navez, Raymond Reding, Jean-François Gigot, Christine Sempoux,